Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure Index in Patients With Diabetic Foot Ulcer

NCT ID: NCT07070544

Last Updated: 2025-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

79 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diabetic foot ulcers (DFUs) are a significant complication of diabetes mellitus, associated with poor peripheral circulation, neuropathy, and increased risk of lower-limb amputation. Optimizing peripheral blood flow is critical in the prevention and management of DFUs. Traditional offloading strategies, such as customized foot insoles, have demonstrated efficacy in reducing plantar pressure and promoting ulcer healing.

Electromagnetic field (EMF) therapy is a non-invasive modality that has shown potential in enhancing microcirculation, promoting angiogenesis, and modulating inflammatory processes. Preliminary studies have suggested that EMF may improve peripheral circulation and tissue oxygenation in diabetic patients.

This study aims to investigate the combined effect of EMF therapy and customized foot insoles on peripheral circulation and Ankle-Brachial Pressure Index (ABPI) in patients with diabetic foot ulcers, hypothesizing that this integrated approach may yield superior outcomes compared to standard care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

2\. Objectives

Primary Objective:

• To evaluate the effect of EMF therapy combined with customized foot insoles on peripheral circulation in patients with diabetic foot ulcers.

Secondary Objective:

* To assess changes in Ankle-Brachial Pressure Index (ABPI) following intervention.
* To compare the ulcer healing rates and pain levels between intervention and control groups.

3\. Research Questions
1. Does the combination of EMF therapy and customized foot insoles improve peripheral circulation in patients with diabetic foot ulcers?
2. Is there a significant improvement in ABPI in the intervention group compared to control?
3. What is the effect of the intervention on ulcer healing rates and pain reduction?

\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
4. Hypotheses
* H1: EMF therapy combined with customized foot insoles significantly improves peripheral circulation compared to standard care.
* H2: EMF therapy combined with customized foot insoles significantly improves ABPI in patients with diabetic foot ulcers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus Diabetic Foot Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The study Group

Electromagnetic Field Therapy:

* Frequency: 50 Hz
* Intensity: 5-30 mT
* Duration: 30 minutes/session
* Frequency: 3 sessions/week for 8 weeks

Customized Foot Insoles:

* Individually tailored based on foot pressure mapping and deformity.
* Designed to offload pressure points and support foot arches.

Standard Care:

• Wound care, glycemic control, and patient education as per institutional protocol.

Group Type ACTIVE_COMPARATOR

Electromagnetic Field Therapy: • Frequency: 50 Hz • Intensity: 5-30 mT • Duration: 30 minutes/session • Frequency: 3 sessions/week for 8 weeks Customized Foot Insoles: • Individually tailored based on

Intervention Type DEVICE

Electromagnetic Field Therapy:

* Frequency: 50 Hz
* Intensity: 5-30 mT
* Duration: 30 minutes/session
* Frequency: 3 sessions/week for 8 weeks

Customized Foot Insoles:

* Individually tailored based on foot pressure mapping and deformity.
* Designed to offload pressure points and support foot arches.

Standard Care:

• Wound care, glycemic control, and patient education as per institutional protocol.

The control group

Standard Care:

• Wound care, glycemic control, and patient education as per institutional protocol.

Group Type PLACEBO_COMPARATOR

Electromagnetic Field Therapy: • Frequency: 50 Hz • Intensity: 5-30 mT • Duration: 30 minutes/session • Frequency: 3 sessions/week for 8 weeks Customized Foot Insoles: • Individually tailored based on

Intervention Type DEVICE

Electromagnetic Field Therapy:

* Frequency: 50 Hz
* Intensity: 5-30 mT
* Duration: 30 minutes/session
* Frequency: 3 sessions/week for 8 weeks

Customized Foot Insoles:

* Individually tailored based on foot pressure mapping and deformity.
* Designed to offload pressure points and support foot arches.

Standard Care:

• Wound care, glycemic control, and patient education as per institutional protocol.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electromagnetic Field Therapy: • Frequency: 50 Hz • Intensity: 5-30 mT • Duration: 30 minutes/session • Frequency: 3 sessions/week for 8 weeks Customized Foot Insoles: • Individually tailored based on

Electromagnetic Field Therapy:

* Frequency: 50 Hz
* Intensity: 5-30 mT
* Duration: 30 minutes/session
* Frequency: 3 sessions/week for 8 weeks

Customized Foot Insoles:

* Individually tailored based on foot pressure mapping and deformity.
* Designed to offload pressure points and support foot arches.

Standard Care:

• Wound care, glycemic control, and patient education as per institutional protocol.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Diagnosed with Type 2 Diabetes Mellitus.

* Presence of unilateral or bilateral diabetic foot ulcer.
* ABPI between 0.6 - 1.0 (mild to moderate arterial insufficiency).

Exclusion Criteria

* • Severe peripheral arterial disease (ABPI \<0.5).

* Active infection requiring hospitalization.
* History of amputation.
* Cardiac pacemaker or contraindication to EMF therapy.
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

South Valley University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ibrahim Abuzaid

Ibrahim ismail Abuzaid

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ibrahim ismail Abuzaid, PhD

Role: CONTACT

+962777956592 ext. +201006512150

References

Explore related publications, articles, or registry entries linked to this study.

Burhan A, Arofiati F, Da Silva VA, Sebayang SM. Effect of Ankle Brachial Index (ABI) and Compression Therapy on Diabetic Foot Ulcer Healing. Curr Diabetes Rev. 2024;20(1):e310323215277. doi: 10.2174/1573399819666230331083420.

Reference Type BACKGROUND
PMID: 37005544 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

South Valley University PTh

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.